Literature DB >> 18645006

Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity.

Richard Sullivan1, Geneviève C Paré, Lisa J Frederiksen, Gregg L Semenza, Charles H Graham.   

Abstract

Hypoxia in solid tumors is associated with the development of chemoresistance. Although many studies have focused on the effect of hypoxia on drug-induced apoptosis, the effect of nonapoptotic pathways on hypoxia-induced drug resistance has not been previously investigated. Here, we determined the effects of hypoxia on multiple forms of drug-induced death in human MDA-MB-231 breast carcinoma cells. Clonogenic assays showed that preexposure to hypoxia leads to resistance to various classes of chemotherapeutic agents, including anthracyclines (daunorubicin and doxorubicin), epipodophyllotoxins (etoposide), and anthracenediones (mitoxantrone). Results revealed a high degree of heterogeneity in nuclear and cytoplasmic alterations in response to acute drug exposure; however, the majority of exposed cells displayed morphologic and biochemical changes consistent with drug-induced senescence. Hypoxia decreased only the proportion of cells in the senescent population, whereas the small proportion of cells exhibiting features of apoptosis or mitotic catastrophe were unaffected. Similar results were obtained with human HCT116 colon carcinoma cells, indicating that the protective effect of hypoxia on drug-induced senescence is not unique to MDA-MB-231 cells. Treatment of MDA-MB-231 cells with small interfering RNA targeting the alpha-subunit of hypoxia-inducible factor-1 (HIF-1), a key regulator of cellular adaptations to hypoxia, prevented hypoxia-induced resistance. HIF-1alpha small interfering RNA also selectively abolished the hypoxia-induced changes in the senescent population, indicating that the increased survival was due to protection against drug-induced senescence. These results support a requirement for HIF-1 in the adaptations leading to drug resistance and reveal that decreased drug-induced senescence is also an important contributor to the development of hypoxia-induced resistance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18645006     DOI: 10.1158/1535-7163.MCT-08-0198

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  84 in total

1.  Role of hypoxia-inducible transcription factor 1alpha for progression and chemosensitivity of murine hepatocellular carcinoma.

Authors:  Katjana Daskalow; Nadine Rohwer; Esther Raskopf; Evelyne Dupuy; Anja Kühl; Christoph Loddenkemper; Bertram Wiedenmann; Volker Schmitz; Thorsten Cramer
Journal:  J Mol Med (Berl)       Date:  2010-04-12       Impact factor: 4.599

2.  Hypoxia-induced oxidative stress promotes MUC4 degradation via autophagy to enhance pancreatic cancer cells survival.

Authors:  S Joshi; S Kumar; M P Ponnusamy; S K Batra
Journal:  Oncogene       Date:  2016-04-25       Impact factor: 9.867

3.  Engineered Breast Cancer Cell Spheroids Reproduce Biologic Properties of Solid Tumors.

Authors:  Stephanie L Ham; Ramila Joshi; Gary D Luker; Hossein Tavana
Journal:  Adv Healthc Mater       Date:  2016-09-07       Impact factor: 9.933

4.  Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop.

Authors:  Ke Xu; Yueping Zhan; Zeting Yuan; Yanyan Qiu; Haijing Wang; Guohua Fan; Jie Wang; Wei Li; Yijun Cao; Xian Shen; Jun Zhang; Xin Liang; Peihao Yin
Journal:  Mol Ther       Date:  2019-06-04       Impact factor: 11.454

5.  Bone microenvironment has an influence on the histological response of osteosarcoma to chemotherapy: retrospective analysis and preclinical modeling.

Authors:  Vincent Crenn; Kevin Biteau; Jérôme Amiaud; Clotilde Dumars; Romain Guiho; Luciano Vidal; Louis-Romée Le Nail; Dominique Heymann; Anne Moreau; François Gouin; Françoise Redini
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

6.  The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells.

Authors:  F F Blanco; M Jimbo; J Wulfkuhle; I Gallagher; J Deng; L Enyenihi; N Meisner-Kober; E Londin; I Rigoutsos; J A Sawicki; M V Risbud; A K Witkiewicz; P A McCue; W Jiang; H Rui; C J Yeo; E Petricoin; J M Winter; J R Brody
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

7.  The oncogene HER2/neu (ERBB2) requires the hypoxia-inducible factor HIF-1 for mammary tumor growth and anoikis resistance.

Authors:  Kelly A Whelan; Luciana P Schwab; Sergey V Karakashev; Lisa Franchetti; Gregg J Johannes; Tiffany N Seagroves; Mauricio J Reginato
Journal:  J Biol Chem       Date:  2013-04-12       Impact factor: 5.157

8.  Principles of ligand binding within a completely buried cavity in HIF2alpha PAS-B.

Authors:  Jason Key; Thomas H Scheuermann; Peter C Anderson; Valerie Daggett; Kevin H Gardner
Journal:  J Am Chem Soc       Date:  2009-12-09       Impact factor: 15.419

9.  Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells.

Authors:  Zhenyu Ding; Li Yang; Xiaodong Xie; Fangwei Xie; Feng Pan; Jianjun Li; Jianming He; Houjie Liang
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-09       Impact factor: 4.553

10.  Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaB.

Authors:  Nadine Rohwer; Christof Dame; Anja Haugstetter; Bertram Wiedenmann; Katharina Detjen; Clemens A Schmitt; Thorsten Cramer
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.